Peptide Therapy, Personalized for You.

A GLP-1 receptor agonist. Certain FDA-approved semaglutide products have indications that include chronic weight management in qualifying patients. It can influence appetite and food intake.

A dual GIP/GLP-1 receptor agonist. Certain FDA-approved tirzepatide products are indicated for chronic weight management in qualifying adults.

A growth-hormone-releasing factor analog. Its FDA-approved indication is reduction of excess abdominal fat in adults with HIV-associated lipodystrophy; it is not approved as a general weight-loss drug.

A modified growth-hormone fragment that has been investigated for metabolic and fat-related applications. It is not an FDA-approved weight-loss medication.

A mitochondrial-derived peptide studied in relation to metabolic signaling and cellular energy. Human therapeutic evidence remains limited.

A small-molecule compound often grouped into metabolic wellness programs. It is not itself a peptide and is not FDA-approved for weight loss.

Nicotinamide adenine dinucleotide is a naturally occurring coenzyme involved in cellular energy metabolism and redox reactions. It is commonly incorporated into wellness programs, but it is not proven to reverse aging.

A mitochondria-derived peptide researched for metabolic and cellular signaling. Human clinical evidence for longevity applications remains limited.

A mitochondria-targeting peptide studied for effects on mitochondrial function and oxidative stress.

A synthetic peptide discussed in aging-related research. It should not be considered a clinically established treatment for reversing aging.

Peptides discussed in experimental bioregulatory and longevity settings. Evidence supporting routine anti-aging use is limited.

An experimental peptide widely discussed for tissue and gastrointestinal research. It is not FDA-approved for orthopedic injury healing.

Related to thymosin beta-4 and discussed in wound-healing and tissue-repair research. Established human clinical evidence is limited.

A common wellness-market name for a BPC-157/TB-500 combination. Both components are investigational for routine injury-recovery use.

A short peptide fragment associated with alpha-MSH and studied in inflammatory and tissue-related pathways. Human safety data are limited.

A naturally occurring antimicrobial peptide involved in innate immune biology. Its therapeutic use remains investigational.

A thymic peptide investigated for immune-modulating effects. Appropriate use depends on medical evaluation and product availability.

A synthetic GHRH analog studied for its ability to stimulate GH/IGF-1 signaling. It is not FDA-approved for athletic performance or anti-aging.

A growth-hormone secretagogue that acts through the ghrelin receptor. Common wellness uses are not FDA-approved indications.

A combination designed around two different pathways of GH signaling. Any use requires individualized medical review.

A synthetic growth-hormone-releasing hormone analog that stimulates pituitary GH secretion rather than supplying growth hormone directly.

A GH-axis combination discussed in some medical-wellness settings. Uses outside tesamorelin's approved indication require appropriate clinical judgment.

A naturally occurring copper-binding peptide researched in skin and tissue biology. Topical cosmetic products should be distinguished from injectable compounded GHK-Cu.

A product or formulation name used by some compounding pharmacies. Ingredients can vary, so your provider should review the exact formulation supplied.

A formulation name that may differ by pharmacy. The exact ingredients, intended use and dosing must be confirmed from the dispensing formulation.

A melanocortin receptor agonist. An FDA-approved bremelanotide product exists for a specific sexual-health indication in qualifying premenopausal women; other uses should not be represented as FDA-approved.

A naturally occurring peptide involved in reproductive hormone signaling through the hypothalamic-pituitary-gonadal axis.

A naturally occurring peptide hormone with established physiological roles. Wellness and sexual-health uses should be discussed separately from approved medical indications.

An experimental peptide discussed in neurological and cognitive research. It is not FDA-approved in the United States as a cognitive enhancer.

An investigational peptide studied for potential neurological and anxiety-related effects. It should not be presented as a proven anxiety treatment.

Delta sleep-inducing peptide has been investigated in sleep-related research, but evidence is insufficient to consider it an established insomnia treatment.

Growth-hormone secretagogues studied for GH signaling. They are not FDA-approved as general performance or anti-aging treatments.

A long-acting IGF-1 analog used in research settings. It is not an FDA-approved wellness or performance medication.

An experimental peptide derivative studied in inflammatory and nerve-related research. Routine wellness uses are investigational.